NCT05141864View on ClinicalTrials.gov

Acmella Oleracea in the Analgesia of the Digital Rectal Examination

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

June 5, 2021

Study Completion Date

November 5, 2021

Conditions
Analgesia in the Digital Rectal Examination
Interventions
BIOLOGICAL

Acmella oleracea gel

Study group will use Acmella oleracea gel during the digital rectal examination.

DRUG

Lidocaine 2 % Topical Cream

Control group will use lidocaine 2% gel during the digital rectal examination.

OTHER

Ultrasound gel

Control group will use ultrasound gel during the digital rectal examination.

Trial Locations (1)

37550-000

Universidade do Vale do Sapucaí, Pouso Alegre

All Listed Sponsors
lead

Universidade do Vale do Sapucai

OTHER

NCT05141864 - Acmella Oleracea in the Analgesia of the Digital Rectal Examination | Biotech Hunter | Biotech Hunter